1. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary
- Author
-
Alessia Gimelli, Christoph Rischpler, Panagiotis Georgoulias, Hein J. Verberne, Gilbert Habib, Andor W. J. M. Glaudemans, Jan Bucerius, Marc R. Dweck, Fabien Hyafil, Paola Anna Erba, Riemer H. J. A. Slart, Mark Lubberink, Olivier Gheysens, Antti Saraste, Tanja Kero, Oliver Gaemperli, Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, University Medical Center Groningen [Groningen] (UMCG), Cliniques Universitaires Saint-Luc [Bruxelles], Uppsala University, University of Edinburgh, Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Hirslanden Medical Center, Department of Radiology, Turku PET Center, Turku University Hospital, University of Turku, Fondazione Toscana Gabriele Monasterio, Univ Hosp Larissa, Department of Radiology and Nuclear Medicine [Amsterdam], VU University Medical Center [Amsterdam], University Medical Center Göttingen (UMG), University of Duisburg-Essen, CIC - CHU Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, University of Pisa - Università di Pisa, Univ Groningen, COMBE, Isabelle, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Universität Duisburg-Essen = University of Duisburg-Essen [Essen], Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Translational Immunology Groningen (TRIGR), Cardiovascular Centre (CVC), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, and UCL - (SLuc) Service de médecine nucléaire
- Subjects
medicine.medical_specialty ,Standardization ,[SDV]Life Sciences [q-bio] ,Medizin ,Joined procedurals ,Computed tomography ,030204 cardiovascular system & hematology ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Eacvi/Eanm Recommendation ,Fluorodeoxyglucose F18 ,Positron Emission Tomography Computed Tomography ,Medical imaging ,medicine ,Humans ,AcademicSubjects/MED00200 ,Radiology, Nuclear Medicine and imaging ,Cardiac PET/CT • Joined procedurals • 4Is • cardiovascular diseases ,4I ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,General Medicine ,Reference Standards ,Cardiovascular disease ,3. Good health ,[SDV] Life Sciences [q-bio] ,Clinical trial ,4Is ,Cardiovascular diseases ,Joined procedural ,Cardiovascular Diseases ,Cardiac PET ,Positron emission tomography ,Positron-Emission Tomography ,Radiology ,Radiopharmaceuticals ,Ct imaging ,Cardiac PET/CT ,Cardiology and Cardiovascular Medicine ,business - Abstract
With this summarized document we share the standard for positron emission tomography (PET)/(diagnostic)computed tomography (CT) imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is) as recently published in the European Journal of Nuclear Medicine and Molecular Imaging. This standard should be applied in clinical practice and integrated in clinical (multicentre) trials for optimal standardization of the procedurals and interpretations. A major focus is put on procedures using [18F]-2-fluoro-2-deoxyglucose ([18F]FDG), but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this summarized document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicentre trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Diagnosis and management of 4Is related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/magnetic resonance, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.
- Published
- 2021